Emerging Options for the Management of Non-Small Cell Lung Cancer
Daniel Binder, Karin Hegenbarth
- ISSN / E-ISSN
- — / —
- DOI
- 10.4137/cmo.s10269 ↗
- Volume · Issue · Pages
- 7 · — · 221-34
- Publisher
- Libertas Academica Ltd.
- Article URL
- https://doi.org/10.4137/cmo.s10269 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Jan 2013
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Jan 2013 | OpenAlex |
Keywords (as given): non-small cell lung cancer; EGFR inhibitors; ALK inhibitors; anti-angiogenic therapy; MET inhibitors; driver mutations; advanced lung cancer; systemic therapy; targeted therapy
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Clinical Medicine Insights: Oncology
- Publication date used
- 01 Jan 2013 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.